Matches in Nanopublications for { ?s ?p "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 29 of
29
with 100 items per page.
- NP90166.RAYWdWXNmemD4q02cnDrihU-NIlaKUJc8AaQCqr9tewNE130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90166.RAYWdWXNmemD4q02cnDrihU-NIlaKUJc8AaQCqr9tewNE130_provenance.
- NP122323.RAec40g4otAJIyCt8g3J2OeCnD0_HlNyk18IQtDKs9rL0130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122323.RAec40g4otAJIyCt8g3J2OeCnD0_HlNyk18IQtDKs9rL0130_provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP120325.RAbdE4uWduRUztP2wb2yF93KavCJX5JZN1UvVEKxjXySM130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120325.RAbdE4uWduRUztP2wb2yF93KavCJX5JZN1UvVEKxjXySM130_provenance.
- NP120327.RAbulmS2ZEOLvz4DVFCUCk37y7aJEV8pG9XGqSOBqgv2A130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120327.RAbulmS2ZEOLvz4DVFCUCk37y7aJEV8pG9XGqSOBqgv2A130_provenance.
- NP62238.RAupb-aYUpRSFQOr-iCW3uzLWjOJOF27tAE-P3TwfWB3I130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62238.RAupb-aYUpRSFQOr-iCW3uzLWjOJOF27tAE-P3TwfWB3I130_provenance.
- NP86674.RAo7lMj-AtgJwmyKjI3C2PcbM-4BE8uE6pLRT-pDF2UJ0130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86674.RAo7lMj-AtgJwmyKjI3C2PcbM-4BE8uE6pLRT-pDF2UJ0130_provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP120322.RAm-JW1gbciVg34gY1uFd08oHVbZEEPmodQbzo3p5_7J8130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120322.RAm-JW1gbciVg34gY1uFd08oHVbZEEPmodQbzo3p5_7J8130_provenance.
- NP78730.RAwtcTyz_RnypSW1Ma4ry8HBzI9glU5akHmt_ivW5ufZs130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78730.RAwtcTyz_RnypSW1Ma4ry8HBzI9glU5akHmt_ivW5ufZs130_provenance.
- NP80048.RAyQNVhXuLajQft8YlC4wAR67f7rKbaHppMYxwle93oXQ130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80048.RAyQNVhXuLajQft8YlC4wAR67f7rKbaHppMYxwle93oXQ130_provenance.
- NP98690.RAIoijguJ0kYcgY0tWjYKafLwlyHa5J67760M_BYM3cLI130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP98690.RAIoijguJ0kYcgY0tWjYKafLwlyHa5J67760M_BYM3cLI130_provenance.
- NP100036.RAEnU3Bx9LpfKrSoto73GxDJ1uyi6eHXcP-mfSS--N5Dg130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100036.RAEnU3Bx9LpfKrSoto73GxDJ1uyi6eHXcP-mfSS--N5Dg130_provenance.
- NP100040.RAKyPSzci14veqZYeh2meFkP2ivnEzq0H0z_FSwaYmSkc130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100040.RAKyPSzci14veqZYeh2meFkP2ivnEzq0H0z_FSwaYmSkc130_provenance.
- NP120319.RAFVa3ao94bmrVrpMQi27kTV3JiWvQui7tqoAr-AKEdnU130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120319.RAFVa3ao94bmrVrpMQi27kTV3JiWvQui7tqoAr-AKEdnU130_provenance.
- NP120321.RAJRNj6LaKNluic1ixkrmO136n_y-CmBxjHZTGpL9xnl0130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120321.RAJRNj6LaKNluic1ixkrmO136n_y-CmBxjHZTGpL9xnl0130_provenance.
- NP120324.RAHp8GBb8ig1XjnrerYqCkahflQpRKQ2nu-qDNh0ZOskw130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120324.RAHp8GBb8ig1XjnrerYqCkahflQpRKQ2nu-qDNh0ZOskw130_provenance.
- NP120318.RA7-tTsnI53kFKTGLodNbA1p3UhWOschrf-NGb3hdHwf4130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120318.RA7-tTsnI53kFKTGLodNbA1p3UhWOschrf-NGb3hdHwf4130_provenance.
- NP120320.RA_0h1cTvV-BuUjasPPfIxg4FfptLlvQGRFWFPwHKIz9o130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120320.RA_0h1cTvV-BuUjasPPfIxg4FfptLlvQGRFWFPwHKIz9o130_provenance.
- NP120323.RA0xSsWMEOFhBjiZobG_2Y_mZFnESyhVLBfhhg5YfjjTA130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120323.RA0xSsWMEOFhBjiZobG_2Y_mZFnESyhVLBfhhg5YfjjTA130_provenance.
- NP120326.RAzCMYOUfqYZIeL3yH6wocZQOAFHFLomKTy3sz6ANE_OE130_assertion description "[IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120326.RAzCMYOUfqYZIeL3yH6wocZQOAFHFLomKTy3sz6ANE_OE130_provenance.